AULSF (Austar Lifesciences) Construction In Progress: $2.2 Mil (As of Dec. 2025)


AULSF Austar Lifesciences Ltd AULSF
48 GF Score
Price $0.07
GF Value $0.10
! 6 Warning Signs
View Full Analysis

What is Austar Lifesciences Construction In Progress?

Austar Lifesciences AULSF 48 Construction In Progress is $2.2 Mil as of Dec. 2025. GuruFocus rates AULSF with a GF Score™ of 48/100 and a GF Value™ of $0.10. The stock has 6 warning signs investors should review.

Austar Lifesciences's quarterly construction in progress increased from Dec. 2024 ($0.7 Mil) to Jun. 2025 ($1.9 Mil) and increased from Jun. 2025 ($1.9 Mil) to Dec. 2025 ($2.2 Mil).

Austar Lifesciences's annual construction in progress increased from Dec. 2023 ($0.6 Mil) to Dec. 2024 ($0.7 Mil) and increased from Dec. 2024 ($0.7 Mil) to Dec. 2025 ($2.2 Mil).

Austar Lifesciences Construction In Progress Historical Data

* Premium members only.

The historical data trend for Austar Lifesciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Austar Lifesciences Construction In Progress Chart

Austar Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.28 30.70 0.63 0.69 2.24

Austar Lifesciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.70 0.69 1.90 2.24
AULSF
48GF Score
Austar Lifesciences Ltd AULSF
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Austar Lifesciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $2.2 Mil mean?
Austar Lifesciences (AULSF) has a Construction In Progress of $2.2 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Austar Lifesciences and its competitors.
Is Austar Lifesciences' Construction In Progress too high?
Austar Lifesciences' current Construction In Progress is $2.2 Mil. Overall, Austar Lifesciences has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Austar Lifesciences' Construction In Progress compare to ABT and SYK?
Austar Lifesciences' Construction In Progress of $2.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Austar Lifesciences and its competitors. Austar Lifesciences's current Construction In Progress is $2.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austar Lifesciences stock overvalued right now?
Austar Lifesciences (AULSF) has a current Construction In Progress of $2.2 Mil. The stock's GF Value™ is $0.10, compared to a current price of $0.07 — trading 30% below its estimated fair value. The current Construction In Progress is $2.2 Mil. Austar Lifesciences' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Austar Lifesciences (AULSF), the current Construction In Progress is $2.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Austar Lifesciences (AULSF) Overvalued in 2026?

Based on GuruFocus' analysis, Austar Lifesciences stock appears to be undervalued. The current stock price of $0.07 is trading 30% below its estimated GF Value™ of $0.10.

Key valuation signals for AULSF:

  • Construction In Progress: $2.2 Mil
  • GF Value™: $0.10 vs. price of $0.07 (30% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the AULSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Austar Lifesciences Business Description

Other Exchanges 06118:Hong Kong
Address No.1018 Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
48GF Score

Get the complete analysis for AULSF

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price
$0.10
GF Value